The order for the 9820 Xenon Polariser system was from the University of British Columbia, but the unit will be installed at the BC Children's Hospital, a leading paediatric research and teaching centre.
Polarean chief executive Richard Hullihen said: "We have now delivered and installed our latest polariser, which is a platform for the researchers at BC Children's Hospital, expanding our paediatric research cluster which includes Cincinnati Children's Hospital Medical Center and Toronto SickKids Hospital.
“We look forward to enabling their new discoveries in these critical projects and we welcome UBC to the group."
The company has developed a drug-device combination which uses xenon gas as a contrast agent in magnetic resonance imaging.
By inhaling and holding a small amount of the gas for just a few seconds, the patient is able to create a much stronger MRI signal, providing doctors with multiple images of lung structure and function.